NCT02552186

Brief Summary

Pectus excavatum (PE), the most common congenital chest wall deformity, requires surgical repair when the degree of deformity is severe. Currently, the Pectus Index (PI) is used to classify PE severity. Calculation of the PI requires cross-sectional imaging of the chest, usually with computed tomography (CT) or Magnetic Resonance Imaging (MRI), to obtain the necessary measurements. However, CT delivers a high dose of ionizing radiation, which carries cumulative long-term risks of malignancy and MRI can be costly. The purpose of this study is to develop a method whereby accurate chest wall measurements can be obtained to quantify PE severity without the need for cross-sectional imaging.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
199

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

September 15, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 17, 2015

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2020

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

3.8 years

First QC Date

September 15, 2015

Last Update Submit

June 28, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • Sensitivity of clinically-derived threshold versus CT/MRI-derived thresholds

    Sensitivity refers to the ability of the test to correctly identify those patients with the disease.

    5 years

  • Specificity of clinically-derived threshold versus CT/MRI-derived thresholds

    Specificity refers to the ability of the test to correctly identify those patients without the disease.

    5 years

  • Receiver operator characteristic curve of clinically-derived threshold versus CT/MRI-derived thresholds

    plot of the true positive rate against the false positive rate for the different possible cutpoints of a diagnostic test.

    5 years

Secondary Outcomes (3)

  • Correlation coefficient

    5 years

  • Cohen's Kappa coefficient

    5 years

  • Agreement between Clinical Pectus Index (CPI) and Pectus Index (PI)-derived from CT or MRI

    5 years

Study Arms (2)

Pectus Excavatum Group

ACTIVE COMPARATOR

The first group (PE Group) will consist of patients presenting to the All Children's Hospital Johns Hopkins Medicine (ACH JHM) Pediatric Surgery or Cardiac Surgery Clinics and the outpatient clinic system at Johns Hopkins Hospital for evaluation of pectus excavatum. Clinical measurements will be obtained using calipers.

Other: Caliper measurement

Control Group

NO INTERVENTION

The second group (Control Group) will be age and gender matched patients presenting to the Radiology department of ACH JHM undergoing CT chest for indications other than chest wall deformity.

Interventions

Clinical caliper measurements will be taken and used to calculate the Clinical PI

Pectus Excavatum Group

Eligibility Criteria

Age11 Years - 21 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Group A (PE Group): All patients evaluated in the ACH JHM Pediatric Surgery or Cardiac Surgery Clinics, as well as in the outpatient clinic system at Johns Hopkins Hospital, for surgical correction of Pectus Excavatum.
  • Group B (Control Group): Age and gender matched patients who undergo chest CT at the ACH JHM Radiology Department for indications other than Pectus Excavatum.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins All Children's Hospital

St. Petersburg, Florida, 33701, United States

Location

MeSH Terms

Conditions

Funnel Chest

Condition Hierarchy (Ancestors)

Bone Diseases, DevelopmentalBone DiseasesMusculoskeletal DiseasesMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Nicole Chandler, MD

    JHACH

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2015

First Posted

September 17, 2015

Study Start

September 1, 2015

Primary Completion

June 1, 2019

Study Completion

December 1, 2020

Last Updated

July 3, 2023

Record last verified: 2023-06

Locations